CARLSBAD, Calif.--(BUSINESS WIRE)--Regulus Therapeutics Inc., a leading microRNA therapeutics company, today announced the appointment of Hubert C. Chen, M.D., as Vice President of Translational Medicine. At Regulus, Dr. Chen will be responsible for leading the translation of the important biological discoveries in the field of microRNA therapeutics into new medicines.
